{"product_id":"duchenne-muscular-dystrophy-camilla-bernardini-9781493973736","title":"Duchenne Muscular Dystrophy: Methods and Protocols","description":"\u003cp\u003e\u003cb\u003ePart I: Reviews and Overview Chapters\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e \u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1. \u003c\/b\u003e\u003cb\u003eAn Overview of Recent Therapeutics Advances for Duchenne Muscular Dystrophy\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e Jean K. Mah\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e\u003cb\u003e2. Clinical Manifestations and Overall Management Strategies for Duchenne Muscular Dystrophy\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e Takeshi Tsuda\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart II: Skeletal and Cardiac Muscle in DMD\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e \u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3. \u003c\/b\u003e\u003cb\u003eCardiac Involvement in Duchenne Muscular Dystrophy and Related Dystrophinopathies\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e Sophie I. Mavrogeni, George Markousis-Mavrogenis, Antigoni Papavasiliou, George Papadopoulos, and Genovefa Kolovou\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e\u003cb\u003e4. Characterization of the Inflammatory Response in Dystrophic Muscle Using Flow Cytometry\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e Jenna M. Kastenschmidt, Ileen Avetyan, and S. Armando Villalta\u003c\/p\u003e \u003cp\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5. Imaging Analysis of the Neuromuscular Junction in Dystrophic Muscle\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e Stephen J.P. Pratt, Shama R. Iyer, Sameer B. Shah, and Richard M. Lovering\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart III: Omics Approaches\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e \u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e6. \u003c\/b\u003e\u003cb\u003eSystem Biology Approach: Gene Network Analysis for Muscular Dystrophy\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e Federica Censi, Giovanni Calcagnini, Eugenio Mattei, and Alessandro Giuliani\u003c\/p\u003e \u003cp\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e7. Proteomic Profiling of the Dystrophin-Deficient Brain\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e Sandra Murphy and Kay Ohlendieck\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e\u003cb\u003e8. Probing the Pathogenesis of Duchenne Muscular Dystrophy Using Mouse Models\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e Alexander Morrison-Nozik and Saptarsi M. Haldar\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart IV: Exon Skipping and Antisense Oligonucleotides (ASOs)\u003c\/b\u003e\u003c\/p\u003e \u003cb\u003e \u003c\/b\u003e\u003cp\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e9. Exon Skipping Therapy Using Phosphorodiamidate Morpholino Oligomers in the \u003ci\u003emdx\u003c\/i\u003e52 Mouse Model of Duchenne Muscular Dystrophy\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e Shouta Miyatake, Yoshitaka Mizobe, Hotake Takizawa, Yuko Hara, Toshifumi Yokota, Shin'ichi Takeda, and Yoshitsugu Aoki\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e\u003cb\u003e10. Designing Effective Antisense Oligonucleotides for Exon Skipping\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e Takenori Shimo, Rika Maruyama, and Toshifumi Yokota\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e\u003cb\u003e11. \u003c\/b\u003e\u003cb\u003eIdentification of Splicing Factors Involved in \u003ci\u003eDMD\u003c\/i\u003e Exon Skipping Events Using an In Vitro RNA Binding Assay\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e Julie Miro, Cyril F. Bourgeois, Mireille Claustres, Michel Koenig, and Sylvie Tuffery-Giraud\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e\u003cb\u003e12. The Use of Antisense Oligonucleotides for the Treatment of Duchenne Muscular Dystrophy\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e Karima Relizani and Aurelie Goyenvalle\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e\u003cb\u003e13. PMO Delivery System Using Bubble Liposomes and Ultrasound Exposure for Duchenne Muscular Dystrophy Treatment\u003c\/b\u003e\u003c\/p\u003e Yoichi Negishi, Yuko Ishii, Kei Nirasawa, Eri Sasaki, Yoko Endo-Takahashi, \u003cp\u003e\u003c\/p\u003e \u003cp\u003eRyo Suzuki, and Kazuo Maruyama\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart V: Biomarkers and Drug Discovery\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e \u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e14. Proton Nuclear Magnetic Resonance (\u003csup\u003e1\u003c\/sup\u003eH NMR) Spectroscopy-Based Analysis of Lipid Components in Serum \/ Plasma of Patients with Duchenne Muscular Dystrophy (DMD)\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e Niraj Kumar Srivastava\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e\u003cb\u003e15. Test of Anti-Fibrotic Drugs in a Cellular Model of Fibrosis Based on Muscle-Derived Fibroblasts from Duchenne Muscular Dystrophy Patients\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e Simona Zanotti and Marina Mora\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e\u003cb\u003e16. Flow Cytometry-Defined CD49d Expression in Circulating T-Lymphocytes is a Biomarker for Disease Progression in Duchenne Muscular Dystrophy\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e Wilson Savino, Fernanda Pinto-Mariz, and Vincent Mouly\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart VI: Last Discoveries and Future Prospectives\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e \u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e17. Advanced Methods to Study the Cross-Talk Between Fibro-Adipogenic Progenitors and Muscle Stem Cells\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e Luca Tucciarone, Usue Etxaniz, Martina Sandoná, Silvia Consalvi, Pier Lorenzo Puri, and V\u003cbr\u003e\u003cbr\u003e\u003cb\u003eAuthor:\u003c\/b\u003e Camilla Bernardini\u003cbr\u003e\u003cb\u003eISBN-10:\u003c\/b\u003e 1493973738\u003cbr\u003e\u003cb\u003eISBN-13:\u003c\/b\u003e 9781493973736\u003cbr\u003e\u003cb\u003ePublisher:\u003c\/b\u003e Humana\u003cbr\u003e\u003cb\u003eLanguage:\u003c\/b\u003e English\u003cbr\u003e\u003cb\u003ePublished:\u003c\/b\u003e 10\/25\/2017\u003cbr\u003e\u003cb\u003ePages:\u003c\/b\u003e 287\u003cbr\u003e\u003cb\u003eFormat:\u003c\/b\u003e Hardcover\u003cbr\u003e\u003cb\u003eWeight:\u003c\/b\u003e 1.64lbs\u003cbr\u003e\u003cb\u003eSize:\u003c\/b\u003e 10.00h x 7.00w x 0.69d\u003c\/p\u003e","brand":"Camilla Bernardini","offers":[{"title":"Hardcover","offer_id":44058560135423,"sku":"9781493973736","price":169.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/2982\/9887\/files\/img_d37a5d13-d010-4e36-9c77-b3ddbfef49d7.jpg?v=1685053265","url":"https:\/\/www.whiterainbookhouse.com\/products\/duchenne-muscular-dystrophy-camilla-bernardini-9781493973736","provider":"WR Book House","version":"1.0","type":"link"}